Biocon gets nod to transfer Biosimilars business to Biocon Biologics

27 Oct 2017 Evaluate

Biocon has received its board’s approval to transfer its Biosimilars business by way of a slump sale as ‘going concern’ to Biocon Biologics India, a step down wholly owned subsidiary of the Company, subject to consent of the shareholders of the Company and obtaining all requisite regulatory / statutory approvals.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

384.05 -8.75 (-2.23%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×